Observational data suggest that periodic breathing is more common in subjects with low F ETCO 2 , high apnoeic thresholds or high chemoreflex sensitivity. It is, however, difficult to determine the individual effect of each variable because they are intrinsically related. To distinguish the effect of isolated changes in chemoreflex sensitivity, mean F ETCO 2 and apnoeic threshold, we employed a modelling approach to break their obligatory in vivo interrelationship. We found that a change in mean CO 2 fraction from 0.035 to 0.045 increased loop gain by 70 ± 0.083% (P < 0.0001), irrespective of chemoreflex gain or apnoea threshold. A 100% increase in the chemoreflex gain (from 800 l min −1 (fraction CO 2 ) −1 ) resulted in an increase in loop gain of 275 ± 6% (P < 0.0001) across a wide range of values of steady state CO 2 and apnoea thresholds. Increasing the apnoea threshold F ETCO 2 from 0.02 to 0.03 had no effect on system stability. Therefore, of the three variables the only two destabilizing factors were high gain and high mean CO 2 ; the apnoea threshold did not independently influence system stability. Although our results support the idea that high chemoreflex gain destabilizes ventilatory control, there are two additional potentially controversial findings. First, it is high (rather than low) mean CO 2 that favours instability. Second, high apnoea threshold itself does not create instability. Clinically the apnoea threshold appears important only because of its associations with the true determinants of stability: chemoreflex gain and mean CO 2 .
Periodic breathing is self-sustaining oscillations of cardiac and respiratory parameters, with cyclical periods of apnoea and hyperpnoea approximately once per minute. It occurs in some patients with chronic heart failure (Hanly et al. 1989b; Sin et al. 1999; Silva et al. 2001) , and is an adverse prognostic indicator (Hanly & Zuberi-Khokhar, 1996; Lanfranchi et al. 1999; Sin et al. 2000; Bradley & Floras, 2003; Corra et al. 2006) . This unstable pattern of control arises from overshoot of the time-delayed negative feedback mechanisms controlling ventilation (Douglas & Haldane, 1909; Cherniack et al. 1979) . This results
Re-use of this article is permitted in accordance with the creative commons Deed, atribution 2.5, which does not permit commercial exploitation. from excessive and/or delayed ventilatory responses to alterations in CO 2 levels, which leads to a vicious circle of inappropriate feedback responses. Physiological variables that are known to interact to determine system stability include chemoreflex delay and gain, alveolar volume and cardiac output (Francis et al. 1999a; Francis et al. 2000b) .
Many clinical studies both from our group and others have found that accompanying the respiratory oscillations in periodic breathing there are significant haemodynamic oscillations, and that system stability determines both respiratory and cardiac oscillations (Faber et al. 1990; Davies et al. 2000; Francis et al. 2000a) .
Previously it was thought that these haemodynamic oscillations may have a causative role in periodic breathing (Ben-Dov et al. 1992) . This was based on the observation that the amplitude ofV O 2 oscillations is larger than the amplitude ofV E oscillations in periodic breathing, and theV O 2 oscillations occur earlier in the periodic breathing cycle. This led the authors to conclude that ventilation alone cannot be driving the oscillations iṅ V O 2 , and therefore the cardiac system must have a role (Ben-Dov et al. 1992) . However, subsequent theoretical work by our group (Francis et al. 1999b ) used a more rigorous mathematical approach to analyse the effect of cyclic fluctuations in ventilation onV O 2 andV CO 2 . We reanalysed the data of Ben-Dov et al. (1992) using this new mathematical approach, and found that theV O 2 andV CO 2 oscillations could be entirely explained by the fluctuations in alveolar ventilation. Clinical work by our group (Francis et al. 1999a ) which specifically controlled for the confounding factors in the work of Ben-Dov et al. (1992) demonstrated that simple oscillations in ventilation in volunteers produce exactly the oscillations iṅ V O 2 andV CO 2 that would be expected. Therefore although haemodynamic oscillations may be present in periodic breathing, they are not necessary in the genesis of the instability and therefore it is reasonable in modelling studies to consider cardiac output as broadly stable in the vicinity of the steady state.
There are two opposing hypotheses about the influence of a subject's carbon dioxide levels on ventilatory stability. Observational clinical studies have reported an association between low mean arterial CO 2 or high apnoeic thresholds and unstable ventilatory control (Skatrud & Dempsey, 1983; Modarreszadeh et al. 1995; Javaheri & Corbett, 1998) . Moreover, since apnoea is preceded by hyperventilation driving arterial CO 2 below an 'apnoea threshold' , it has been argued a high apnoea threshold can encourage instability (Cherniack et al. 1966; Naughton et al. 1993) . The potential steady state is the point of intercept of the chemoreflex response and the curve of metabolic production of CO 2 (isometabolic curve). If the chemoreflex response curve is constrained to be linear, the intercept (C apn ) is determined by the steady state CO 2 (C ) and chemoreflex gain (S):
An alternative hypothesis is that the apnoeic threshold is not itself an independent determinant of system stability, but that it only appears to be so because it is intimately related to the chemoreflex gain and mean CO 2 . In a system with a linear chemoreflex response, the apnoeic threshold is geometrically constrained to be linked to mean F ETCO 2 and the chemoreflex gain (Fig. 1) . The chemoreflex slope equals the potential steady state ventilation divided by the difference between potential steady state CO 2 and the apnoeic threshold CO 2 . This makes it extremely difficult to extricate the influence of each independent variable on ventilatory control by clinical observation.
In contrast to clinical studies, mathematical models allow the effect of individual parameters to be assessed independently. However, although there have been several such models of periodic breathing, these typically include an enforced linear chemoreflex relationship meaning that it is still impossible to examine the independent effect of the apnoeic threshold on ventilatory stability.
We present a mathematical model deliberately designed to allow any combination of potential steady state CO 2 and ventilation, chemoreflex gain and apnoeic threshold. The aim of this study was to apply this model to assess the stability of the resultant control system, separating the relative contributions to ventilatory stability of potential steady state CO 2 , chemoreflex slope and apnoeic threshold.
Methods

Chemoreflex control of ventilation
Ventilatory stability depends on the interplay of two physiological mechanisms. The first is chemoreflex gain: the effect that a change in end-tidal CO 2 has on ventilation. This corresponds to controller gain in standard control theory. The second is exhalation gain, corresponding to plant gain -the effect that a change in ventilation has on end-tidal carbon dioxide (F ETCO 2 ).
The central role of the potential steady state
In ventilatory control the two key variables are ventilation and CO 2 . Mean F ETCO 2 is linked to ventilation according to a hyperbolic curve (Fig. 1) if CO 2 exhalation is to match metabolic production of CO 2 (V CO 2 ) in the body.
If a particular alveolar ventilation rate (V A ) is maintained in the medium term, F ETCO 2 is destined to becomeV CO 2 /V A (the isometabolic curve). Ventilation in turn depends on F ETCO 2 through the chemoreflex response curve. Given these constraints, there is only one combination of F ETCO 2 and ventilation which can be sustained: this is called the potential steady state. Regardless of whether the system is stable or unstable, the potential steady state values of F ETCO 2 and alveolar ventilation can be defined to be the crossing point of ) at NERL Consortia on October 29, 2010 jp.physoc.org Downloaded from J Physiol ( these two lines. Whether this potential steady state will be achieved is determined by the configuration of the control system.
In general, system stability is dependent on its behaviour around the potential steady state. If the system configuration responds to a small deviation away from the potential steady state by moving progressively closer back to the potential steady state, then the system is stable ( Fig. 2A) .
If, on the other hand, the system configuration is such that its responses to a small deviation cause progressively larger deviations from the potential steady state, then the system will be unstable. In this case the steady state exists only in potential form -i.e. a central point around which system oscillations occur (Fig. 2B) . to fourth oscillations prior to the system reaching its final outcome pattern.
In an unstable system, the presence of apnoeas prevents the size of oscillations increasing beyond a particular amplitude, and therefore eventually the ratio of amplitudes of consecutive oscillations becomes 1.
The model
A simple iterative model can be used to map system behaviour in response to a perturbation (in the form of a small transient change in ventilation or F ETCO 2 from potential steady state), and thereby determine whether ventilatory control will be stable. The model creates a chemoreflex response curve using our chosen values of chemoreflex gain, potential steady state F ETCO 2 and apnoeic threshold. Since the chemoreflex response is created synthetically in the model, any desired shape of response can be created, which allows us to separately adjust chemoreflex gain and apnoea threshold (Fig. 3) .
Clinical data suggest that although the chemoreflex response curve is linear near potential steady state values of F ETCO 2 , it is non-linear (concave) near the apnoea threshold (Mohan & Duffin, 1997) .
The model plots the response in F ETCO 2 and ventilation to the perturbation, given the particular chemoreflex response curve characteristics. The ventilation and F ETCO 2 Figure 3 . A special curved shape of the chemoreflex response allowing chemoreflex slope and apnoea threshold to be changed independently The inset shows a magnified region near the potential steady state, indicating 3 chemoreflex slopes. The main figure shows 3 possible apnoea thresholds. Allowing the chemoreflex response to be curved permits any of the chemoreflex slopes to be combined with any of the apnoea thresholds, giving a total of 9 different chemoreflex response curves.
can therefore oscillate with ever-decreasing amplitude back to the potential steady state (loop gain < 1; stable control), or the oscillations can increase in amplitude (loop gain > 1; unstable control).
To prevent unnecessary duplication of entities representing CO 2 levels, in this model we use just two variables. Arterial and end-tidal CO 2 move largely in parallel, so as long as ventilation and cardiac output are close to their potential steady state, one can be used as a proxy for the other, providing we remain aware that there may be an offset between the two. The F ETCO 2 has additional meaning as (in combination with alveolar ventilation) it completely determines the amount of CO 2 that is exhaled by the body, and simultaneously (in combination with alveolar volume) it describes the volume of CO 2 stored in the lungs. We therefore choose to use end-tidal CO 2 fraction (F ETCO 2 ) as the single variable to represent CO 2 status. To describe chemoreflex responses in these terms, we must recognize that chemoreflexes sense not current F ETCO 2 , but rather the level of CO 2 in the blood that was in contact with lung CO 2 several seconds previously (equivalent to the chemoreflex delay, δ). We can represent this time-delayed value of CO 2 using a subscript (c t −δ ).
We incorporated this information into the equation based on a standard single-compartment model (Francis et al. 2000b) to describe how the rate of change in F ETCO 2 depends on the rate of CO 2 production by metabolism following removal by ventilation and circulatory buffering (Francis et al. 2000b) . The potential steady state F ETCO 2 is represented by C, potential steady state ventilation asV A, and the current value of CO 2 and ventilation at time t, as v and c, respectively. The buffering of CO 2 by the circulation and extrapulmonary stores depends on β, the solubility of CO 2 in blood, andQ, the mean cardiac output.
The dependency of rate of change of F ETCO 2 on the other variables can be derived to be as follows (Francis et al. 1999a; 2000b) :
We calculated and plotted the fixed curve for the set of potential steady state pairs of CO 2 and alveolar ventilation based on the requirement that their mutual product must equal metabolic production of CO 2 (V CO 2 ). We created a modifiable function ('chemoreflex function') which described the chemoreflex response: this could be configured to give a large gain (such as in a patient with heart failure), or small gain (such as in a normal subject). Our values for chemoreflex gain were taken from clinical data measured by several different groups, using a range of methodologies (Khoo et al. 1995; Mohan et al. 1999; Van den Aardweg & Karemaker, 2002; Beecroft et al. 2006) . We initialized the model from its potential steady state, and then introduced a small perturbation in CO 2 . The model then iteratively calculated successive pairs of values of v (using the chemoreflex function and the appropriate previous value of c) and dc/dt (using eqn (1)). Thus the course of v and c could be plotted for several minutes of simulated time. The details of the model are given as accompanying online Supplemental material.
We used standard values for the cardiorespiratory parameters that were held constant throughout our investigations: cardiac output (Q) = 3.5 l min −1 , (Gabrielsen et al. 2002; Turner et al. 2004) .
Results
Study 1. Linear chemoreflex response
The simplest shape of the chemoreflex response is a linear function (Fig. 1) . Changing any one of chemoreflex gain (S), C or C apn necessitates a change in one of the others.
Study 1A. Changing chemoreflex gain and apnoea threshold. First we assessed the effect of altering the chemoreflex gain programmed into the model, whilst maintaining the potential steady state CO 2 constant. Because in this study the shape of the chemoreflex response is linear, when chemoreflex gain is altered, the apnoea threshold must change (as shown in Fig. 1) .
The simulation was run 5 times with chemoreflex gain taking values of 500, 900, 950, 1000 and 1500 (1000 l min −1 fraction −1 F ETCO 2 is equivalent to 1.3 l min −1 mmHg −1 or 9.9 l min −1 kPa −1 ). These values range from those observed in normal subjects to ones that would be typical for a patient with heart failure and periodic breathing (Javaheri, 1999; Francis et al. 2000b) .
We found that increased chemoreflex gain and apnoeic threshold readily destabilized ventilatory control (Fig. 4A) . In the unstable systems, chemoreflex slope also determined the amplitude of oscillations in ventilation and CO 2 in the final outcome pattern.
However, from this study in isolation, it is impossible to identify which of these two parameters is responsible for the alterations in ventilatory stability.
Study 1B. Changing the apnoea threshold and potential steady state values of CO 2 and ventilation. We then used the model to investigate the effect of changing both the levels of potential steady state CO 2 and the apnoea threshold, whilst maintaining an unchanging chemoreflex gain. Again, due to the linearity of the model, a higher potential steady state CO 2 at a fixed chemoreflex gain required a higher apnoea threshold.
As the values of apnoea threshold and potential steady state increased, ventilatory control destabilized (Fig. 4B) .
Study 1C. Changing chemoreflex gain and potential
steady state values of CO 2 and ventilation. In the third study, we altered the third possible pair of these three physiological variables: potential steady state CO 2 and chemoreflex gain. As the chemoreflex gain was increased and potential steady state CO 2 reduced, the system became more unstable (Fig. 4C ).
Potential explanations for Studies 1A, 1B and 1C. From studying the results of Study 1, an observer might propose three possible explanations:
an increase in chemoreflex gain is destabilizing, an increase in apnoea threshold is destabilizing, and the level of CO 2 at potential steady state has no effect; an increase in both the levels of CO 2 at potential steady state and at the apnoea threshold are destabilizing, and the chemoreflex gain has no effect; an increase in the chemoreflex gain and a decrease in the potential steady state value of CO 2 are destabilizing and the apnoea threshold has no effect.
The only way to determine which of these explanations is correct is to study the effect of changing each of the three variables separately. To vary C, C apn and S independently requires a specially devised model, which we created for Study 2. A, the effect of C and C apn on system stability. We maintained the chemoreflex at a fixed value but used different combinations of potential steady state CO 2 (C ) and apnoeic threshold (C apn ). This showed that as C increased, system stability decreased. C apn however, had no effect on stability. B, the effect of C and chemoreflex gain on system stability. We maintained the apnoeic threshold at a constant value and found that as either the chemoreflex gain and C increase, Study 2. Separately investigating the independent effects of chemoreflex gain, apnoea threshold and potential steady state
In order to change one of the variables (C, C apn or S) without altering the others, we introduced curvature into the shape of the chemoreflex response near its lower end. This allows it to pass through any chosen apnoea threshold, while maintaining the chosen value of chemoreflex slope around the potential steady state (Fig. 3) .
Study 2A. Effect of the apnoeic threshold in isolation on system stability. We tried a range of values for apnoea threshold fraction (0.0200-0.0375), whilst maintaining the chemoreflex gain at 950 l min −1 fraction −1 and the potential steady state fractional CO 2 at 0.04. These values were selected because in the models of Study 1 they were found to be at the borderline of stability, which meant they were most likely to be informative in Study 2: small changes in system stability would be readily detectable.
We found apnoea threshold had no effect on system stability ( Fig. 5A) : β = 0.032, P ≥ 0.99.
Study 2B. Effect of chemoreflex gain in isolation on system stability. We then changed chemoreflex sensitivity, maintaining potential steady state CO 2 and apnoea threshold unchanged.
We found that even subtle changes in chemoreflex sensitivities result in large shifts of system stability ( Fig. 5B) : the 25% increase in chemoreflex gain between cases 2 and 4 causes loop gain to increase by 82%. The unstandardized β coefficient on linear regression was 0.02 (standardized β = 0.998), P ≤ 0.0001. Study 2C. Effect of potential steady state CO 2 in isolation on system stability. We set the chemoreflex gain at 900 l min −1 fraction −1 , and the apnoea threshold at 0.035 whilst changing the potential steady state level of CO 2 (and hence ventilation) over a narrow range. As the potential steady state value of CO 2 increased, respiratory control was found to become more unstable (Fig. 5C ). The unstandardized β regression coefficient on linear regression was 62.3 (standardized β = 1.0), P ≤ 0.0001.
Study 3. Independently varying two parameters
To visualize the independent effects of chemoreflex gain and apnoea threshold, we tested a range of combinations of values of these variables, displaying the resulting loop gains on a 3D plot.
there is a reduction in system stability. C, the effect of C apn and chemoreflex gain on system stability. Again increases in chemoreflex gain were found to increase system instability, and again apnoeic threshold did not affect stability.
When potential steady state CO 2 fraction increased from 0.035 to 0.045, with constant chemoreflex gain, mean loop gain increased by 70 ± 0.083%, P < 0.0001 (Fig. 6A) . This was true irrespective of the apnoea threshold, giving additional evidence that the apnoea threshold does not influence system stability.
When chemoreflex gain was increased from 800 to 1600 l min −1 fraction −1 with potential steady state CO 2 held constant (Fig. 6C) , the loop gain increased by 275 ± 6% (P < 0.0001). Again, there was no change in loop gain over a wide range of apnoea thresholds.
In Fig. 6B the chemoreflex gain and potential steady state CO 2 were changed in combination, without changing apnoea threshold. Increasing chemoreflex gain from 800 to 1600 l min −1 (fraction CO 2 ) −1 , increased mean loop gain by 248 ± 24% (P < 0.0001). When potential steady state CO 2 fraction increased from 0.035 to 0.045 there was a mean loop gain increase of 44 ± 26% (P = 0.03).
Therefore, supporting our findings in Study 2, we found using multiple combinations of parameters of C, C apn and chemoreflex gain, only C and chemoreflex gain influenced system stability. Apnoea threshold had no independent effect on stability.
Study 4. The effect of initial perturbation size on ventilatory stability
Although the results of studies 1, 2 and 3 have shown us which of the three variables tested contribute to system stability, the model has also demonstrated that the relevant part of the chemoreflex response is the 'average slope' over the range of F ETCO 2 which the patient experiences.
Any steep portions of the chemoreflex response curve, near the central potential steady state point, contribute Figure 7 . Effect on stability of different initial perturbations sizes in F ETCO 2 , with system configuration otherwise kept identical A, an 'unstable' chemoresponse system: it develops a consistent pattern of oscillations irrespective of the size of the initial perturbation. From a small initial perturbation (top right) the loop gain is clearly initially > 1, while from a large initial oscillation (top left) the loop gain is clearly initially < 1. A system that has loop gain > 1 from a small perturbation definitely cannot be stable. In contrast a loop gain < 1 from large perturbation does not guarantee stability: it might indicate that the system will settle into oscillations of smaller size than the initial perturbation. B, a 'stable' chemoresponse system: irrespective of the initial perturbation, ventilation and F ETCO 2 revert back towards steady state values. Loop gain is < 1 for all perturbation sizes including the small perturbations which are the type of stimuli that truly distinguish stable from unstable systems. Thus loop gain is only a straightforward indicator of stability when calculated for small disturbances. Hypothetically therefore if a chemoreflex response curve has a 'convex' shape, it would have an especially steep segment just above the apnoea threshold, and this additional contribution to 'average' slope could make a significant impact on stability. In this hypothetical state, it is conceivable that a system could be just stable if initiated in the shallow-sloped region close to the steady state point, but be unstable if initiated at apnoea (giving the patient exposure to the steep part of the curve near apnoea).
However, real physiological measurements of the chemoreflex response curve performed by several previous workers, using a variety of techniques including modified Read's rebreathing and dynamic end-tidal forcing, have shown no evidence of a steepening of the chemoreflex response near the apnoea threshold. In fact, if there is any curvature of the chemoreflex response, the available data Figure 8 . A small change in the apnoeic threshold hides a large change in the chemoreflex gain If the potential steady state is maintained at a constant value, and only the apnoeic threshold is measured, it would appear that there has only been a small change in the input parameters. Closer inspection, however, shows that although the apnoea threshold has only increased by 14%, the chemoreflex gain doubled.
indicate that the slope at lower F ETCO 2 is typically flatter (Mohan et al. 1999) , as shown in Fig. 1 of Jensen et al. (2005) .
We therefore tested the effect of different-sized initial perturbations on ventilatory stability, first in a system that was 'unstable' with a small initial perturbation, and subsequently in a 'stable' system. We found that in an 'unstable' system a small perturbation (Fig. 7A , case 1) will result in an initial loop gain > 1, whereas a large perturbation (Fig. 7A , case 5) may result in an initial loop gain of < 1. In both situations however, the final outcome pattern of the system is the same.
In the 'stable' system, however, the initial loop gain is always < 1, regardless of perturbation size.
Clearly therefore loop gain is a useful summary of system stability only when measured for small initial perturbations. Perturbation size does not affect the final outcome pattern, but large initial perturbations may settle to smaller long-term oscillations in the final outcome pattern (Table 1) .
Discussion
This modelling approach gives a unique opportunity to distinguish individual contributions of different . Figure 9 . A higher inspired level of CO 2 narrows the gap between end-tidal CO 2 levels and inspired CO 2 The result is that ventilation rises, and so for a constant metabolic production of CO 2 there is a new potential steady state and a fall in plant gain.
variables which in clinical practice are inextricably linked.
In the first phase of this study, using a model with linear properties, we observed that ventilatory control becomes more unstable if chemoreflex gain increases (with potential steady state CO 2 falling), if chemoreflex gain increases (with the apnoeic threshold also increasing) or if both potential steady state and apnoeic levels of CO 2 rise together. Potentially there might be three contradictory explanations for these data:
high chemoreflex gain and high C apn each destabilize control (with C having no effect); high steady state CO 2 (C ) and high C apn each destabilize control (but chemoreflex gain has no effect); high chemoreflex gain and C each destabilize control (but C apn has no effect).
The only way to separate these possibilities was to modify the chemoreflex function to remove its constraint of a linear chemoreflex slope. Doing so yielded two potentially controversial findings: r high, rather than low, levels of CO 2 favour system instability; r apnoea threshold itself has no influence on ventilatory These findings superficially appear to conflict with widely held clinical opinion, which is that low average CO 2 levels predispose to unstable ventilatory control (Skatrud & Dempsey, 1983; Naughton et al. 1993; Xie et al. 1994; Javaheri, 1999) . For example, it was reported that low arterial CO 2 in heart failure patients is a powerful predictor of central sleep apnoea (Javaheri & Corbett, 1998 ).
Yet the results of our study indicate that low potential steady state CO 2 is stabilizing rather than destabilizing. We believe this apparent inconsistency between model findings and clinical observations is because the clinical observations rarely include the quantitatively most important determinant of respiratory control stability: chemoreflex gain. Clinical studies more often measure C and/or C apn (Modarreszadeh et al. 1995; Javaheri & Corbett, 1998) . Dempsey et al. (2004) and Dempsey (2005) concluded that the key determinants of system stability are plant gain, chemoreflex gain and 'CO 2 ' reserve (the difference between steady state CO 2 and the apnoea threshold), but clinical data cannot separate these parameters.
If chemoreflex gain is not measured, then the only observable differences between the stable and unstable patients may be small differences in C apn and C. For example, in Fig. 8 , there is a twofold difference in the chemoreflex gain between the subject modelled in the left panel and that in the right, but that this is manifest as only a 14% difference in C apn . This may give the false impression that high C apn is mechanistically important in causing instability, whereas in reality it is the large difference in chemoreflex gain that is important. The apnoeic threshold (C apn ) has no independent effect on stability, and indeed, in isolation, low C would actually favour stability rather than instability.
This distinction is not simply academic, because incorrect belief in a stabilizing effect of increased potential steady state CO 2 may result in incorrect design of treatment strategies.
Our work and that of others since the beginnings of mathematical modelling of periodic breathing (Mackey & Glass, 1977) have consistently found that C levels and chemoreflex gain have a multiplicative effect on stability: a 1% rise in chemoreflex gain has an identical effect on system stability as a 1% increase in C (Francis et al. 2000b) . The potential confusion arises because clinically, very large differences in chemoreflex gain may accompany small differences in C, and therefore the strong destabilizing effect of the high chemoreflex will certainly overcome the small change in C.
The reason why small changes in C can conceal large changes in chemoreflex gain is due to the mandatory relationships between the chemoreflex gain, C and the apnoeic threshold under the constraint of a linear chemoreflex response. From the triangular shape of Fig. 1 , we can readily derive this relationship:
Small changes in C, because it is effectively a 'squared' term on the denominator, can be associated with large changes in chemoreflex gain.
How does supplemental inhaled CO 2 assist stability?
A second conundrum is the well recognized observation that raising ambient CO 2 concentration can help to stabilize ventilatory control in some patients (Badr et al. 1994; Steens et al. 1994; Lorenzi-Filho et al. 1999) . This would appear to contradict our model results, which indicate that raised levels of potential steady state CO 2 are destabilizing.
This apparent paradox can be readily explained if one considers that an elevation in inspired CO 2 concentration will firstly result in a net reduction in the proportion of CO 2 produced by metabolism that is exhaled with each breath. As inspired CO 2 concentration increases, each litre of alveolar ventilation per minute at the same F ETCO 2 excretes less net CO 2 from the body. This is equivalent to a rightward shift of the isometabolic curve by F ICO 2 . Quantitatively the curve of metabolically sustainable states changes fromV
The location of the new potential steady state (the new crossing point of the chemoreflex response curve with the new isometabolic curve) therefore moves rightwards and upwards as shown in Fig. 9 . At this new potential steady state, the higher average ventilation means that a 1 l min −1 disturbance in ventilation has a smaller absolute effect on F ETCO 2 , i.e. the plant gain has fallen. The result is a smaller total loop gain, i.e. a more stable system (Francis et al. 2000b) .
This effect of an increased concentration of inhaled CO 2 has a similar stabilizing effect on ventilatory control to pharmacologically induced hyperventilation (Nakayama et al. 2002) .
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How might supplemental oxygen assist stability?
The administration of oxygen during sleep has been shown to reduce sleep apnoea (Hanly et al. 1989a; Ponikowski et al. 1999) . This could be due to a reduction in the net chemoreflex gain. First, the degree of CO 2 sensitivity increases with hypoxia, and therefore one would expect elimination of hypoxia to reduce CO 2 chemoreflex gain. Second, oscillations in arterial oxygen may contribute to some degree to the oscillations in ventilation. Elimination of these oscillations by hyperoxia may therefore further favour stability.
Do our findings conflict with previous modelling studies?
There have been previous modelling studies which also used approaches that allow investigation of the effect of chemoreflex gain and the apnoea threshold on ventilatory stability. For example, our group has previously created an analytical model to identify the causative factors that lead to periodic breathing, and then we performed clinical validation in human subjects (Francis et al. 2000b) . The clinical data identified chemoreflex gain as a powerful destabilizing factor on ventilatory stability, and the theoretical analysis also indicated that high potential steady state levels of CO 2 are a destabilizing factor. Khoo et al. (1982 Khoo et al. ( , 1991 have created other mathematical models and also assessed the effects of chemoreflex gain and potential steady state CO 2 levels on ventilatory stability. They found that system instability is increased by hypercapnia and large chemoreflex gain amongst other factors. Carley & Shannon (1988b) developed a mathematical model using a frequency domain approach. This model too indicated that high ventilation enhanced system stability, whereas high CO 2 was destabilizing. Miyamoto et al. (2004) clinically validated the concept of the CO 2 regulatory system being divided into controller gain (the ventilatory response to inspired CO 2 ), and plant gain (the arterial CO 2 response to changes in ventilation). They were able to measure controller gain and plant gain (the reciprocal of the slope of the hyperbola at the potential steady state), and therefore estimate total loop gain. They too found that at higher ventilation plant gain is lower and the system more stable.
The effect of raised inspired CO 2 on ventilatory stability has also been assessed by Topor et al. (2004) using a comprehensive computational model. They deduced that raised F ICO 2 stabilizes control by increasing mean ventilation.
The independent role of the apnoeic threshold has less often been studied in mathematical models. Vielle (2000) used a model that could alter both the chemoreflex gain and CO 2 levels, and again found that elevated values of either parameter led to decreased stability. He used C apn threshold as an index for CO 2 levels, but as C was not described separately, C apn acted as a proxy for C. Any change in the apnoeic threshold would therefore be automatically associated with a similar increment in potential steady state CO 2 . Therefore his finding that a high apnoeic threshold leads to system instability needs to be qualified as it is related to a joint increase in potential steady state CO 2 and chemoreflex gain. His study does not identify which of the two is the true culprit.
Recently, in a review of the mechanisms of periodic breathing, Cherniack & Longobardo (2006) have warned of the importance of studying the behaviour of the respiratory control system near the potential steady state, rather than just focusing on the apnoea threshold.
Taken together, the results of these previous studies are all consistent with the conclusions that we have found in this modelling study. Increased chemoreflex gain and increased mean F ETCO 2 are each able to decrease system stability. Ours is the first model to deliberately assess the independent influence of chemoreflex gain, potential steady state CO 2 and the apnoeic threshold on stability. We have aimed to provide a model that is simple to understand, so that the clinical implications can readily be appreciated.
Limitations of the study
For simplicity, we used only a single variable to represent blood gas variation, in keeping with several previous models (Vielle, 2000) . During periodic breathing at rest, CO 2 and O 2 oscillations are in almost perfect antiphase (Faber et al. 1990 ) and therefore these oscillations can be satisfactorily treated as a single variable, with tacit recognition that the chemoreflex responds both to a rise in CO 2 and correspondingly to a fall in O 2 . Moreover, near the potential steady state, chemoreflex responses to hypoxia are significantly smaller than hypercapnic responses for the same change in partial pressure (Carley & Shannon, 1988a; Maayan et al. 1992) , and therefore the hypoxic contribution should be small.
For simplicity again, we use F ETCO 2 levels as a proxy for all CO 2 levels in the body, making the assumption that changes in one are tracked in parallel by changes in the others (in particular, arterial). This simplification is equivalent to assuming no significant physiological dead space. However, even if there is significant physiological dead space, the principal consequence is that the chemoreflex gains expressed in terms of changes in F ETCO 2 would be numerically smaller than their conventional expression in terms of arterial CO 2 changes. It would have no impact on the relative contributions of the three parameters to system stability, and therefore no effect on the conclusions of this study. The venous CO 2 is taken to not fluctuate significantly during periodic breathing. This substantially simplifies the mathematics and is supported by physiological measurements (Vielle & Chauvet, 1998) .
Our third simplification is to not separate peripheral and central components of the chemoreflex. Although there are multiple clusters of individual chemosensitive cells located in the aorta, the carotids and the brainstem, we describe the 'net' response, with a single effective delay and gain that represents a summation of the responses of all these individual receptors. Treating each component separately substantially increases the complexity and obscurity of the model, but cannot change the conclusions.
We have intentionally used the simplest possible units for each physical quantity in this study. This eliminates the need for arbitrary constants to convert between units. The simplest measure of end-tidal CO 2 level is its fraction, which is dimensionless. As a result, our unit of chemoreflex gain is 'l min −1 (fraction of end-tidal CO 2 ) −1 ' , synonymous with 'l min −1 atm −1 ' , which is unconventional but fulfils the aim of being the simplest possible unit.
Finally, the purpose of this model is not to examine all cardiac and respiratory influences on system stability, but to extricate the independent effects of chemoreflex sensitivity, apnoea threshold and steady state CO 2 , which cannot be separated clinically. This paper therefore adds to previously published clinical studies and mathematical models which aim to comprehensibly identify all influences on system stability -cardiac (including cardiac output and circulation time), respiratory and central (Khoo et al. 1982 (Khoo et al. , 1991 Francis et al. 2000b; Vielle, 2000; Topor et al. 2004; Cherniack & Longobardo, 2006) .
Conclusions
We have found that in contrast to beliefs arising from clinical observation, cardiorespiratory stability in heart failure is not independently affected by the apnoeic threshold. Moreover, in a second apparent conflict with clinical observation, we have found that it is a high (rather than low) potential steady state level of CO 2 that favours instability. In this paper we have explained both of these apparent paradoxes. They arise from the powerful effect of chemoreflex gain, which is infrequently addressedperhaps because it is not automatically available from routine clinical data.
